Clin2
NCT04766177Possibly a fitRecruiting

Bumetanide for children with autism symptoms

Autism

Treatments studied

Part of Mental health clinical trials.

This trial tests whether bumetanide can improve autism symptoms in children. It is for children aged 3 to 12 with autism diagnosed using a standard symptom rating scale.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
80 people
Ages
3 years to 12 years
Study type
Interventional

Who can take part

  • You have a diagnosis of autism (ASD) based on a CARS score of at least 30
  • Your child is between 3 and 12 years old
  • No history of certain brain/nerve problems such as epilepsy
  • No history of fever-related seizures (febrile seizures)
  • No liver problems or kidney problems
  • No heart rhythm or EKG/ECG (EKG) abnormalities

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05501678Recruiting· Phase 2
Diphenhydramine to help sleep in autistic children

This Phase 2 study tests whether diphenhydramine improves sleep in children with autism who have significant sleep problems. It requires sleep monitoring (watch data and sleep testing) and checking for side effects to see if the treatment is safe and helpful.

Stanford, California
NCT07450443Recruiting· Phase 2/Phase 3
Gut health and autism: a study on the gut barrier and bacteria

This trial is looking at the connection between the gut and autism. It tests whether certain gut bacteria and the gut's protective barrier are different in children with autism and gastrointestinal issues. This could help find new ways to improve symptoms.

Milan, MI
NCT07257939Not yet recruiting· Phase 3
Liquid medicine for autism in children and teens

This trial tests an oral liquid medicine (called NTI164) to see if it helps reduce symptoms of autism in children and teens. It may be an option if current treatments haven't fully helped, but it requires regular study visits and certain health rules.

Brisbane, Queensland
NCT07199218Recruiting· Phase 2
Cannabis oil for autism in children aged 4 to 12

This trial tests a cannabis oil enriched with terpenes (natural compounds that may affect behavior) to see if it helps reduce severe symptoms in children with autism. It compares the oil to a placebo.

Jerusalem, N/A = Not Applicable
NCT07622316Recruiting· Phase 1
Autism Research Study for Children Ages 3 and Up

This is an early-stage study exploring a new experimental treatment for autism spectrum disorder (ASD). Researchers will work with your child and family to test whether this approach is safe and how it might help with autism symptoms.

Roswell, Georgia
NCT07439042Recruiting· Phase 4
Buspirone for anxiety in children with autism

This trial tests whether buspirone, a medication that helps with anxiety, can reduce anxiety in children and teens with autism. It is a 12-week study where participants receive buspirone or a placebo (a pill with no medicine) to see if it improves anxiety symptoms.

Lexington, Massachusetts

Hear when a new Autism trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.